J. Veals

595 total citations
20 papers, 397 citations indexed

About

J. Veals is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Spectroscopy. According to data from OpenAlex, J. Veals has authored 20 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Spectroscopy. Recurrent topics in J. Veals's work include Analytical Chemistry and Chromatography (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). J. Veals is often cited by papers focused on Analytical Chemistry and Chromatography (5 papers), Neuroscience and Neuropharmacology Research (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). J. Veals collaborates with scholars based in United States, China and France. J. Veals's co-authors include Walter A. Korfmacher, C.A. Korduba, Samson Symchowicz, Kathleen Cox, Chin‐Chung Lin, Kwokei Ng, Amin A. Nomeir, Ronald E. White, D. B. Prelusky and Lisa Broske and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Life Sciences.

In The Last Decade

J. Veals

19 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Veals United States 10 156 145 63 57 56 20 397
Robert J. Barnaby Italy 10 189 1.2× 49 0.3× 35 0.6× 40 0.7× 64 1.1× 20 473
Karen L Locker United Kingdom 7 124 0.8× 91 0.6× 35 0.6× 21 0.4× 77 1.4× 8 296
Simone Braggio Italy 15 214 1.4× 83 0.6× 32 0.5× 57 1.0× 94 1.7× 25 540
Miyoshi Fukui Japan 13 202 1.3× 73 0.5× 10 0.2× 86 1.5× 43 0.8× 32 527
Jan Paulson Switzerland 9 68 0.4× 144 1.0× 19 0.3× 39 0.7× 21 0.4× 11 347
Bernard Serkiz France 11 229 1.5× 76 0.5× 9 0.1× 32 0.6× 53 0.9× 15 491
Steven M. Winter United States 9 159 1.0× 47 0.3× 17 0.3× 89 1.6× 29 0.5× 13 511
Giuseppe Carbonara Italy 17 397 2.5× 47 0.3× 56 0.9× 22 0.4× 92 1.6× 36 661
Wesley R. Anderson United States 16 153 1.0× 44 0.3× 9 0.1× 22 0.4× 43 0.8× 38 535
Börje Egestad Sweden 13 162 1.0× 56 0.4× 11 0.2× 27 0.5× 35 0.6× 26 462

Countries citing papers authored by J. Veals

Since Specialization
Citations

This map shows the geographic impact of J. Veals's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Veals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Veals more than expected).

Fields of papers citing papers by J. Veals

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Veals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Veals. The network helps show where J. Veals may publish in the future.

Co-authorship network of co-authors of J. Veals

This figure shows the co-authorship network connecting the top 25 collaborators of J. Veals. A scholar is included among the top collaborators of J. Veals based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Veals. J. Veals is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Xiao‐Ying, J. Veals, & Walter A. Korfmacher. (2003). Comparison of conventional and enhanced mass resolution triple‐quadrupole mass spectrometers for discovery bioanalytical applications. Rapid Communications in Mass Spectrometry. 17(8). 832–837. 15 indexed citations
2.
Veals, J., et al.. (2002). Semi-quantitation of acyl glucuronides in early drug discovery by LC-MS/MS. Nottingham Trent University's Institutional Repository (Nottingham Trent Repository). 3 indexed citations
3.
4.
Korfmacher, Walter A., J. Veals, Xiping Zhang, et al.. (1999). Demonstration of the capabilities of a parallel high performance liquid chromatography tandem mass spectrometry system for use in the analysis of drug discovery plasma samples. Rapid Communications in Mass Spectrometry. 13(20). 1991–1998. 49 indexed citations
5.
Veals, J., et al.. (1997). High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma. Journal of Chromatography B. 703. 225–233. 13 indexed citations
6.
Lin, Chin‐Chung, et al.. (1997). High-performance liquid chromatographic determination and stability of 5-(3-methyltriazen-1-yl)-imidazo-4-carboximide, the biologically active product of the antitumor agent temozolomide, in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 703(1-2). 225–233. 39 indexed citations
7.
Lin, Chin‐Chung, et al.. (1997). Analysis of Isepamicin in Human Plasma by Radioimmunoassay, Microbiologic Assay, and High-Performance Liquid Chromatography. Therapeutic Drug Monitoring. 19(6). 675–681. 7 indexed citations
8.
Korfmacher, Walter A., Kathleen Cox, Matthew Bryant, et al.. (1997). HPLC-API/MS/MS: a powerful tool for integrating drug metabolism into the drug discovery process. Drug Discovery Today. 2(12). 532–537. 66 indexed citations
9.
Stoehr, Gary P., et al.. (1985). The Excretion of Rosaramicin in Breast Milk. The Journal of Clinical Pharmacology. 25(2). 89–94. 13 indexed citations
10.
Loebenberg, David, Edwin M. Oden, J. Veals, et al.. (1985). Pharmacokinetics of Sch 34343 in rats and dogs. Journal of Antimicrobial Chemotherapy. 15(suppl C). 219–226. 3 indexed citations
11.
Veals, J., et al.. (1981). Bioavailability of Orally Administered Propiram Fumarate in Humans. Journal of Pharmaceutical Sciences. 70(5). 521–523. 1 indexed citations
12.
Veals, J., C.A. Korduba, & Samson Symchowicz. (1977). Effect of dexamethasone on monoamine oxidase inhibition by iproniazid in rat brain. European Journal of Pharmacology. 41(3). 291–299. 28 indexed citations
13.
Korduba, C.A., J. Veals, & Samson Symchowicz. (1974). Effects of 5-(n-butyl)-picolinamide (SCH 10595), a dopamine-beta-hydroxylase inhibitor, on serotonin and catecholamine metabolites in brain.. PubMed. 190(3). 459–65. 2 indexed citations
14.
Korduba, C.A., J. Veals, A. Wöhl, Samson Symchowicz, & I.I.A. Tabachnick. (1973). SCH 10595, AN EFFECTIVE DOPAMINE-β-HYDROXYLASE INHIBITOR AND A HYPOTENSIVE AGENT. Journal of Pharmacology and Experimental Therapeutics. 184(3). 671–677. 3 indexed citations
15.
Korduba, C.A., J. Veals, & Samson Symchowicz. (1973). The effect of pheniramine and its structural analogues on 5-hydroxytryptamine in rat and mouse brain. Life Sciences. 13(11). 1557–1564. 7 indexed citations
16.
Korduba, C.A., et al.. (1973). SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent.. PubMed. 184(3). 671–7. 7 indexed citations
17.
Symchowicz, Samson, C.A. Korduba, & J. Veals. (1973). The effect of amantadine on radiolabeled biogenic amines in the rat brain. European Journal of Pharmacology. 21(2). 155–160. 11 indexed citations
18.
Symchowicz, Samson, C.A. Korduba, & J. Veals. (1971). Inhibition of dopamine uptake into synaptosomes of rat corpus striatum by chlorpheniramine and its structural analogs. Life Sciences. 10(1). 35–42. 23 indexed citations
19.
Symchowicz, Samson, C.A. Korduba, J. Veals, & I.I.A. Tabachnick. (1968). Norepinephrine biosynthesis in the rat pancreas. Biochemical Pharmacology. 17(11). 2313–2314. 3 indexed citations
20.
Symchowicz, Samson, C.A. Korduba, J. Veals, & I.I.A. Tabachnick. (1966). Duration of the effect of disulfiram on incorporation and metabolism of dopamine-14C in hypertensive rat. Biochemical Pharmacology. 15(10). 1607–1610. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026